版本:
中国

BRIEF-Therapeuticsmd provides TX-004HR regulatory update

April 10 Therapeuticsmd Inc

* Therapeuticsmd provides tx-004hr regulatory update

* Therapeuticsmd Inc - on April 7, received a letter from fda

* Therapeuticsmd-FDA says as part of review of tx-004hr nda, has identified deficiencies preclude discussion of labeling, postmarketing requirements/at this time

* Therapeuticsmd inc - letter states that notification does not reflect a final decision on information under review

* Therapeuticsmd Inc - letter does not specify deficiencies identified by FDA and at this time company is not aware of nature of deficiencies

* Therapeuticsmd Inc - intends to work with fda to understand nature of deficiencies and resolve them as quickly as possible Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐